Recent advances in the synthetic and medicinal perspective of quinolones: A review

P Dhiman, N Arora, PV Thanikachalam, V Monga - Bioorganic Chemistry, 2019 - Elsevier
In the modern scenario, the quinolone scaffold has emerged as a very potent motif
considering its clinical significance. Quinolones possess wide range of pharmacological …

Quinolone: a versatile therapeutic compound class

PS Dube, LJ Legoabe, RM Beteck - Molecular Diversity, 2023 - Springer
The discovery of nalidixic acid is one pinnacle in medicinal chemistry, which opened a new
area of research that has led to the discovery of several life-saving antimicrobial agents …

Antiplasmodial and antimalarial activities of quinolone derivatives: An overview

YL Fan, XW Cheng, JB Wu, M Liu, FZ Zhang… - European Journal of …, 2018 - Elsevier
Malaria remains one of the most deadly infectious diseases globally. Considering the
growing spread of resistance, development of new and effective antimalarials remains an …

Preparation of protamine-hyaluronic acid coated core-shell nanoparticles for enhanced solubility, permeability, and oral bioavailability of decoquinate

W Wei, M Lu, W Xu, NE Polyakov, AV Dushkin… - International Journal of …, 2022 - Elsevier
Decoquinate (DQ) has low oral bioavailability owing to its poor water solubility. In this study,
a DQ solid dispersion (DQ-SD) was fabricated using mechanochemical technology to …

Accessible and distinct decoquinate derivatives active against Mycobacterium tuberculosis and apicomplexan parasites

RM Beteck, R Seldon, D Coertzen… - Communications …, 2018 - nature.com
The quinolone decoquinate is coadministered with feed for treatment of parasites which
cause coccidiosis in poultry. However, from a drug-development perspective, the biological …

Artemisone and artemiside are potent panreactive antimalarial agents that also synergize redox imbalance in Plasmodium falciparum transmissible gametocyte …

D Coertzen, J Reader, M Van Der Watt… - Antimicrobial Agents …, 2018 - Am Soc Microbiol
The emergence of resistance toward artemisinin combination therapies (ACTs) by the
malaria parasite Plasmodium falciparum has the potential to severely compromise malaria …

Topical Delivery of Artemisone, Clofazimine and Decoquinate Encapsulated in Vesicles and Their In vitro Efficacy Against Mycobacterium tuberculosis

L Van Zyl, JM Viljoen, RK Haynes, M Aucamp… - AAPS …, 2019 - Springer
Vesicles are widely investigated as carrier systems for active pharmaceutical ingredients
(APIs). For topical delivery, they are especially effective since they create a “depot-effect” …

The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria

DJ Watson, L Laing, RM Beteck, L Gibhard… - Frontiers in …, 2022 - frontiersin.org
The emergence of Plasmodium falciparum (Pf) parasite strains tolerant of the artemisinin
component and resistant to the other drug component in artemisinin combination therapies …

Elucidating the antimycobacterial mechanism of action of decoquinate derivative RMB041 using metabolomics

KE Knoll, Z Lindeque, AA Adeniji, CB Oosthuizen… - Antibiotics, 2021 - mdpi.com
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), still remains one of the
leading causes of death from a single infectious agent worldwide. The high prevalence of …

An in vitro ADME and in vivo Pharmacokinetic Study of Novel TB-Active Decoquinate Derivatives

L Tanner, RK Haynes, L Wiesner - Frontiers in Pharmacology, 2019 - frontiersin.org
Tuberculosis (TB) is currently the leading cause of mortality due to an infectious disease,
despite the existence of multiple effective first-line and second-line drugs. The current anti …